Picture of Taisho Pharmaceutical Holdings Co logo

4581 — Taisho Pharmaceutical Holdings Co News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Table: Taisho Pharmaceutical HD -9-MTH group results

Feb 3 (Reuters)-  
             Taisho Pharmaceutical Holdings Co Ltd  
             CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                   9 months ended      9 months ended       Year to  
                  Dec 31, 2015        Dec 31, 2014     Mar 31, 2016  
                     LATEST             YEAR-AGO          LATEST     
                     RESULTS             RESULTS         FORECAST    
  Sales              224.98              221.76           290.00     
                   (+1.5 pct)          (-2.7 pct)       (-0.2 pct)   
  Operating           22.72               24.84            27.00     
                   (-8.5 pct)          (-31.9 pct)      (-15.6 pct)  
  Recurring           29.10               30.89            35.00     
                   (-5.8 pct)          (-29.5 pct)      (-11.6 pct)  
  Net                 18.71               19.64            21.50     
                   (-4.8 pct)          (-29.5 pct)      (-12.3 pct)  
  EPS              230.74 yen          242.26 yen       265.23 yen   
  EPS Diluted      230.61 yen          242.15 yen                    
  Ann Div                              110.00 yen       100.00 yen   
  -Q2 div           50.00 yen           50.00 yen                    
  -Q4 div                               60.00 yen        50.00 yen   
   
  NOTE - Taisho Pharmaceutical Holdings Co Ltd.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4581.T 
  ((Tokyo Headline News Desk +813 6441 1812))

Recent news on Taisho Pharmaceutical Holdings Co

See all news